FILTER BY:
Intravitreal antivascular endothelial growth factor therapy has revolution…
Expiration Date: 6/29/2022
Max Credits: 0.75
View Activity
Optimal integration of intravitreal anti-vascular endothelial growth facto…
Expiration Date: 12/21/2021
Max Credits: 1
The management of neovascular retinal disease has been revolutionized by t…
Expiration Date: 12/30/2021
Visual acuity outcomes from real-world analysis of patients with neovascul…
Expiration Date: 12/22/2021
Evolving advances for the treatment of neovascular retinal diseases have t…
Expiration Date: 10/29/2021
Max Credits: 0
Visual outcomes in patients with neovascular age-related macular degenerat…
Expiration Date: 10/20/2021
Sub-analysis of pinnacle trials utilizing anti–vascular endothelial …
Expiration Date: 8/27/2021
Noninfectious uveitis continues to be a leading cause of preventable blind…
Expiration Date: 4/29/2021
Age-related macular degeneration (AMD), a leading cause of blindness in th…
Expiration Date: 4/12/2021
Protocols for the management and treatment of retinal diseases continue to…